Los Angeles Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

Los Angeles Capital Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-27,391	Closed	-$1.86M	–	1387
2019 Q3	$1.86M	Sell	27,391 -480	-2%	-$33K	0.01%	656
2019 Q2	$1.62M	Sell	27,871 -1,750	-6%	-$104K	0.01%	697
2019 Q1	$2.08M	Sell	29,621 -3,170	-10%	-$235K	0.01%	650
2018 Q4	$2.11M	Sell	32,791 -14,000	-30%	-$981K	0.01%	542
2018 Q3	$3.29M	Sell	46,791 -9,760	-17%	-$571K	0.02%	538
2018 Q2	$2.85M	Buy	56,551 +5,630	+11%	+$223K	0.02%	611
2018 Q1	$1.59M	Buy	50,921 +150	+0.3%	+$4.98K	0.01%	705
2017 Q4	$1.74M	Buy	50,771 +24,574	+94%	+$784K	0.01%	715
2017 Q3	$841K	Buy	26,197 +19,390	+285%	+$612K	﹤0.01%	869
2017 Q2	$222K	Sell	6,807 -130	-2%	-$4.12K	﹤0.01%	1137
2017 Q1	$218K	Buy	+6,937	New	+$205K	﹤0.01%	1081

Los Angeles Capital Management's GHDX Position: Q4 2019 in Review

Los Angeles Capital Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 27,391 shares — an estimated $1.86M sold.

Los Angeles Capital Management first reported a position in GHDX in Q1 2017 and held it in 11 quarters. The position peaked at $3.29M in Q3 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Los Angeles Capital Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Los Angeles Capital Management sold 27,391 Genomic Health, Inc. shares in Q4 2019, an estimated $1.86M.
Los Angeles Capital Management first reported a position in Genomic Health, Inc. in Q1 2017 and held it in 11 quarters.
Los Angeles Capital Management's Genomic Health, Inc. position peaked at $3.29M in Q3 2018.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Los Angeles Capital Management's 13F filing for Q4 2019, filed 7 Feb 2020.